Capecitabine induced inflammation of actinic keratoses

Capecitabine, an oral prodrug of 5-fluorouracil, is a systemic chemotherapeutic agent used in the treatment of metastatic breast and colon cancer. Patients undergoing capecitabine therapy may experience inflammation and irritation of existing actinic keratoses. Oncologists and dermatologists alike s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Dermatology online journal 2007-10, Vol.13 (4), p.13
Hauptverfasser:	Krathen, M, Treat, J, James, W D
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antimetabolites, Antineoplastic - adverse effects Breast Neoplasms - drug therapy Breast Neoplasms - secondary Capecitabine Deoxycytidine - adverse effects Deoxycytidine - analogs & derivatives Female Fluorouracil - adverse effects Fluorouracil - analogs & derivatives Humans Inflammation - chemically induced Inflammation - drug therapy Keratosis - etiology Ultraviolet Rays - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Capecitabine, an oral prodrug of 5-fluorouracil, is a systemic chemotherapeutic agent used in the treatment of metastatic breast and colon cancer. Patients undergoing capecitabine therapy may experience inflammation and irritation of existing actinic keratoses. Oncologists and dermatologists alike should be aware of this side effect.
ISSN:	1087-2108 1087-2108
DOI:	10.5070/D33S83X36N